Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 13, 2015

Total Value: $220M (100.0% shares, 0.0% debt)

Holdings (23)

UTHR UNITED THERAPEUTICS CORP 10.3%

Value $22.55M Shares 130,801 Est. Cost $129.95 Unrealized +17.3%

— IMPAX LABORATORIES INC 8.8%

Value $19.26M Shares 410,944 Est. Cost $31.68 Unrealized —

— AMAG PHARMACEUTICALS INC 8.5%

Value $18.64M Shares 341,091 Est. Cost $42.62 Unrealized —

TEVA TEVA PHARMACEUTICAL-SP ADR 7.0%

Value $15.46M Shares 248,200 Est. Cost $58.07 Unrealized —

— HALYARD HEALTH INC 6.8%

Value $14.96M Shares 304,150 Est. Cost $45.92 Unrealized —

— SUCAMPO PHARMACEUTICALS-CL A 6.6%

Value $14.53M Shares 933,866 Est. Cost $14.28 Unrealized —

ENTA ENANTA 5.9%

Value $12.98M Shares 424,016 Est. Cost $38.91 Unrealized 0.0%

CNMD CONMED CORP 5.8%

Value $12.69M Shares 251,274 Est. Cost $36.87 Unrealized +17.4%

MRK MERCK & CO. INC. 5.5%

Value $12.03M Shares 209,304 Est. Cost $39.37 Unrealized +2.4%

OM2 ORTHOFIX INTERNATIONAL NV 5.1%

Value $11.12M Shares 309,698 Est. Cost $30.06 Unrealized —

— HILL-ROM HOLDINGS INC 4.2%

Value $9.228M Shares 188,327 Est. Cost $45.62 Unrealized —

— AMGEN INC 4.1%

Value $9.111M Shares 57,000 Est. Cost $159.55 Unrealized —

— RTI SURGICAL INC 3.8%

Value $8.405M Shares 1,701,458 Est. Cost $5.19 Unrealized —

— DEPOMED INC 3.5%

Value $7.699M Shares 343,546 Est. Cost $16.11 Unrealized —

— ACTAVIS PLC 3.0%

Value $6.534M Shares 21,954 Est. Cost $257.43 Unrealized —

— INVACARE CORP 3.0%

Value $6.498M Shares 334,762 Est. Cost $16.76 Unrealized —

ABBV ABBVIE INC 1.9%

Value $4.098M Shares 70,000 Est. Cost $40.24 Unrealized -3.5%

— BIOTA PHARMACEUTICALS INC 1.4%

Value $3.12M Shares 1,356,652 Est. Cost $2.25 Unrealized —

— INDIVIOR PLC 1.3%

Value $2.817M Shares 1,000,000 Est. Cost $2.82 Unrealized —

— THERAVANCE INC 1.2%

Value $2.534M Shares 161,188 Est. Cost $14.15 Unrealized —

— COLUMBIA LABORATORIES INC 0.9%

Value $1.963M Shares 316,149 Est. Cost $5.60 Unrealized —

— DIGIRAD CORP 0.9%

Value $1.905M Shares 419,604 Est. Cost $4.36 Unrealized —

— FURIEX PHARMACEUTICA CMN 0.6%

Value $1.422M Shares 145,544 Est. Cost $9.77 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	UNITED THERAPEUTICS CORP	130,801	$22.55M	10.3%	$129.95	+17.3%	COM	91307C102
—	IMPAX LABORATORIES INC	410,944	$19.26M	8.8%	$31.68	—	COM	45256B101
—	AMAG PHARMACEUTICALS INC	341,091	$18.64M	8.5%	$42.62	—	COM	00163U106
TEVA	TEVA PHARMACEUTICAL-SP ADR	248,200	$15.46M	7.0%	$58.07	—	COM	881624209
—	HALYARD HEALTH INC	304,150	$14.96M	6.8%	$45.92	—	COM	40650V100
—	SUCAMPO PHARMACEUTICALS-CL A	933,866	$14.53M	6.6%	$14.28	—	COM	864909106
ENTA	ENANTA	424,016	$12.98M	5.9%	$38.91	0.0%	COM	29251M106
CNMD	CONMED CORP	251,274	$12.69M	5.8%	$36.87	+17.4%	COM	207410101
MRK	MERCK & CO. INC.	209,304	$12.03M	5.5%	$39.37	+2.4%	COM	58933Y105
OM2	ORTHOFIX INTERNATIONAL NV	309,698	$11.12M	5.1%	$30.06	—	COM	N6748L102
—	HILL-ROM HOLDINGS INC	188,327	$9.228M	4.2%	$45.62	—	COM	431475102
—	AMGEN INC	57,000	$9.111M	4.1%	$159.55	—	COM	31162100
—	RTI SURGICAL INC	1,701,458	$8.405M	3.8%	$5.19	—	COM	74975N105
—	DEPOMED INC	343,546	$7.699M	3.5%	$16.11	—	COM	249908104
—	ACTAVIS PLC	21,954	$6.534M	3.0%	$257.43	—	COM	G0083B108
—	INVACARE CORP	334,762	$6.498M	3.0%	$16.76	—	COM	461203101
ABBV	ABBVIE INC	70,000	$4.098M	1.9%	$40.24	-3.5%	COM	00287Y109
—	BIOTA PHARMACEUTICALS INC	1,356,652	$3.12M	1.4%	$2.25	—	COM	90694100
—	INDIVIOR PLC	1,000,000	$2.817M	1.3%	$2.82	—	COM	G4766E108
—	THERAVANCE INC	161,188	$2.534M	1.2%	$14.15	—	COM	88338T104
—	COLUMBIA LABORATORIES INC	316,149	$1.963M	0.9%	$5.60	—	COM	197779200
—	DIGIRAD CORP	419,604	$1.905M	0.9%	$4.36	—	COM	253827109
—	FURIEX PHARMACEUTICA CMN	145,544	$1.422M	0.6%	$9.77	—	COM	36106P101